A pioneering Phase II trial reported at the American Association for Cancer Research 2010 annual meeting (abstract number LB-1) is the first to demonstrate the use of multiple biomarkers to guide the ...
Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...
On August 19th, Medtronic released its earnings report for the fiscal first quarter ended July 25th, 2025. The company's ...
The International Drug Development Institute (IDDI) is reinforcing its position as a contract research organization by introducing innovative clinical trial design and analysis solutions that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback